Cabahug, Cenon S.
HRN: 18-65-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
CEFTRIAXONE 1G (VIAL)
06/24/2022
07/01/2022
IV
2gm
Q24hours
Bowel Obstruction
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes